Precision for Medicine and PathAI Collaborate on AI-Powered Clinical Trial Services
Precision for Medicine and PathAI have announced a strategic collaboration to advance AI-powered clinical trial services and biospecimen products, announced in a press release. This partnership aims to integrate PathAI's advanced digital pathology and analysis capabilities into Precision for Medicine's operations, offering novel tools and analytical services for biomarker discovery and tissue-based clinical research.
The collaboration will utilize several PathAI technologies, including the AISight digital pathology image management system, to enhance biospecimen and clinical trial services. These tools will apply algorithm-based quality control steps to biospecimen analysis, improving data consistency and reliability. Additionally, the partnership will leverage machine learning models to reduce complex biomarker panels to actionable insights, aiding in the interpretation of tissue biology.
This collaboration is set to provide unique value to biopharma clients by combining AI tools with Precision for Medicine's proprietary wet lab infrastructure and centralized clinical trial operations. The innovative tools developed through this partnership will be exclusively available through Precision for Medicine's services, offering a level of integration and customization not found elsewhere in the industry.
We hope you enjoyed this article.
Consider subscribing to one of several newsletters we publish like Life AI Weekly.
Also, consider following us on social media:
More from: Healthcare & Life Sciences
Avio Health Unveils Functional Medicine LLM for Personalized Healthcare
Novo Nordisk Foundation Allocates DKK 479 Million for AI and Health Projects
Infinitus Expands AI Partnership with Salesforce for Healthcare
RevelAi Health Secures $3.1 Million to Enhance AI in Musculoskeletal Care
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read more